As of 4:02pm ET
| +1.08 / +0.83%|
The 22 analysts offering 12-month price forecasts for Zimmer Biomet Holdings Inc have a median target of 144.00, with a high estimate of 155.00 and a low estimate of 95.00. The median estimate represents a +10.27% increase from the last price of 130.59.
The current consensus among 28 polled investment analysts is to Buy stock in Zimmer Biomet Holdings Inc. This rating has held steady since August, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.